Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 109
of 6Next
1:

Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta.

Dolcini GL, Solana ME, Andreani G, Celentano AM, Parodi LM, Donato AM, Elissondo N, González Cappa SM, Giavedoni LD, Martínez Peralta L.

Retrovirology. 2008 Jul 1;5:53.

PMID: 18593480 [PubMed - indexed for MEDLINE]

2:

Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner.

Kfutwah AK, Mary JY, Nicola MA, Blaise-Boisseau S, Barré-Sinoussi F, Ayouba A, Menu E.

Retrovirology. 2006 Jun 23;3:36.

PMID: 16796744 [PubMed - indexed for MEDLINE]

3:

Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas' disease.

Lin S, Sartori MJ, Mezzano L, de Fabro SP.

Placenta. 2005 Nov;26(10):789-95. Epub 2005 Aug 24.

PMID: 16122790 [PubMed - indexed for MEDLINE]

4:

Placental alkaline phosphatase (PLAP) study in diabetic human placental villi infected with Trypanosoma cruzi.

Mezzano L, Sartori MJ, Lin S, Repossi G, de Fabro SP.

Placenta. 2005 Jan;26(1):85-92.

PMID: 15664416 [PubMed - indexed for MEDLINE]

5:

Trypanosoma cruzi: productive infection is not allowed by chorionic villous explant from normal human placenta in vitro.

Luján CD, Triquell MF, Sembaj A, Guerrero CE, Fretes RE.

Exp Parasitol. 2004 Nov-Dec;108(3-4):176-81.

PMID: 15582515 [PubMed - indexed for MEDLINE]

6:

Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.

Brener Z, Gazzinelli RT.

Int Arch Allergy Immunol. 1997 Oct;114(2):103-10. Review.

PMID: 9338602 [PubMed - indexed for MEDLINE]

7:

Use of the placental perfusion model to evaluate transplacental passage of Trypanosoma cruzi.

Shippey SH 3rd, Zahn CM, Cisar MM, Wu TJ, Satin AJ.

Am J Obstet Gynecol. 2005 Feb;192(2):586-91.

PMID: 15696007 [PubMed - indexed for MEDLINE]

8:

Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.

Chuenkova M, Pereira ME.

J Exp Med. 1995 May 1;181(5):1693-703.

PMID: 7722448 [PubMed - indexed for MEDLINE]

9:

Trypanosoma cruzi infection induces microfilament depletion in human placenta syncytiotrophoblast.

Sartori MJ, Pons P, Mezzano L, Lin S, de Fabro SP.

Placenta. 2003 Aug;24(7):767-71.

PMID: 12852867 [PubMed - indexed for MEDLINE]

10:

[Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection]

Moreno EA, Rivera IM, Moreno SC, Alarcón ME, Lugo-Yarbuh A.

Invest Clin. 2003 Sep;44(3):241-54. Spanish.

PMID: 14552062 [PubMed - indexed for MEDLINE]

11:

Epidermal growth factor (EGF) in the human placental infection with Trypanosoma cruzi.

Lin S, Sartori MJ, Mezzano L, de Fabro SP.

Placenta. 2004 Apr;25(4):283-6.

PMID: 15028420 [PubMed - indexed for MEDLINE]

12:

A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.

Aparicio IM, Scharfstein J, Lima AP.

Infect Immun. 2004 Oct;72(10):5892-902.

PMID: 15385491 [PubMed - indexed for MEDLINE]

13:

Role of placental alkaline phosphatase in the interaction between human placental trophoblast and Trypanosoma cruzi.

Sartori MJ, Lin S, Frank FM, Malchiodi EL, de Fabro SP.

Exp Mol Pathol. 2002 Feb;72(1):84-90.

PMID: 11784127 [PubMed - indexed for MEDLINE]

14:

[Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]

Braun M, de Titto E.

Acta Physiol Pharmacol Latinoam. 1985;35(1):1-47. Spanish.

PMID: 2932884 [PubMed - indexed for MEDLINE]

15:

[Cellular components and placental alkaline phosphatase in Trypanosoma cruzi infection ]

Sartori MJ, Mezzano L, Lin S, Repossi G, Fabro SP.

Rev Soc Bras Med Trop. 2005;38 Suppl 2:87-91. Spanish.

PMID: 16482823 [PubMed - indexed for MEDLINE]

16:

Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.

Cetron MS, Basilio FP, Moraes AP, Sousa AQ, Paes JN, Kahn SJ, Wener MH, Van Voorhis WC.

Am J Trop Med Hyg. 1993 Sep;49(3):370-82.

PMID: 8372959 [PubMed - indexed for MEDLINE]

17:

Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease.

Sartori AM, Caiaffa-Filho HH, Bezerra RC, do S Guilherme C, Lopes MH, Shikanai-Yasuda MA.

Am J Trop Med Hyg. 2002 Nov;67(5):521-3.

PMID: 12479555 [PubMed - indexed for MEDLINE]

18:

Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.

Sztein MB, Kierszenbaum F.

Immunology. 1992 Oct;77(2):277-83.

PMID: 1427979 [PubMed - indexed for MEDLINE]

19:

[Increase of Hofbauer cells in human placentas cocultured in vitro with Trypanosoma cruzi]

Fretes RE, De Fabro SP.

Rev Fac Cien Med Univ Nac Cordoba. 1994;52(1):7-12. Spanish.

PMID: 7597283 [PubMed - indexed for MEDLINE]

20:

Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil.

Perez-Ramirez L, Barnabé C, Sartori AM, Ferreira MS, Tolezano JE, Nunes EV, Burgarelli MK, Silva AC, Shikanai-Yasuda MA, Lima JN, Da-Cruz AM, Oliveira OC, Guilherme C, Bastrenta B, Tibayrenc M.

Am J Trop Med Hyg. 1999 Aug;61(2):198-206.

PMID: 10463667 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 109
of 6Next